Trial Details
TERMINATEDBasic Information
| Clinical ID | c820 |
|---|---|
| Identifier | NCT04131322 |
| Trial Title | Loss of Response of Adalimumab Biosimilar vs Adalimumab Original, in Inflammatory Bowel Disease. |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn Disease|Ulcerative Colitis |
| Interventions | DRUG: Amgevita 40Mg Solution for Injection|DRUG: HUMIRA 40Mg Solution for Injection |
Participant Information
| Sponsor | Fundación Pública Andaluza para la gestión de la Investigación en Sevilla |
|---|---|
| City | Sevilla |
| Country/Region | Spain |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE4 |
Time Information
| Start Date | 2019-10-10 |
|---|---|
| Primary Completion Date | 2020-06-08 |
| Completion Date | 2020-06-08 |